scindu funding
All calls

Prevention and management of chronic non-communicable diseases in children and young people (GACD)

Horizon Europe · Grant topic

HORIZON-HLTH-2027-01-DISEASE-10

Summary

A Polish company can use this call for R&D.

Funds research supporting childhood chronic disease prevention and management for healthcare stakeholders serving disadvantaged populations and low- and middle-income countries.

Who can apply
Companies can lead: SME, large company, research org, university, public body.
Amount
€3M – €4M per projectTotal budget €11,800,000
Deadline
17 Feb 2027 01:00 CETin 116 days
Status
Forthcomingopens 29 Oct 2026
Open on the portalRegister to keep this call

Machine-classified from the call text; check eligibility at the source.

Description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to some of the following expected outcomes:

• Researchers, healthcare practitioners and providers in low- and middle-income countries (LMICs)[1] and/or those in high-income countries (HICs) serving disadvantaged populations have access to improved insights and evidence on how to equitably promote the early prevention, risk reduction, and timely diagnosis of Non-Communicable Diseases (NCDs) in children and/or young people.

• Policymakers, public health managers and authorities, parents and their children, and young adults have access to evidence and recommendations for national programmes and policies to improve quality of life in children and/or young people and extend healthy life expectancy.

• Researchers, clinicians, policymakers, public health managers and authorities have an improved understanding how to effectively adapt and/or scale up interventions for prevention and management of chronic NCDs in children and/or young people at local, regional, and national levels.

• Communities, parents and their children, young adults, local stakeholders and authorities are fully engaged in implementing and taking up interventions that tackle NCDs in children and/or young people.

Scope:

The Commission is a member of the Global Alliance for Chronic Diseases (GACD)[2]. The GACD specifically addresses NCDs and supports implementation research[3] to improve health outcomes. This topic is launched in concertation with the other GACD members (international funding agencies) and aligned with the 12th GACD call.

Chronic NCDs that begin in childhood have an impact on both quality of life and life expectancy. Onset of many NCDs diseases occurs at younger ages in LMICs, and this is further accompanied by a longer duration of disease and a higher rate of complications, including multimorbidity. The conditions in which people are born, grow and live (the social determinants of health) including access to good nutrition, education, housing, and healthcare are major contributors to health and ill health[4].

Up to 70% of preventable adult deaths from NCDs are linked to risk factors originating in childhood and adolescence[5], and interventions that can successfully control or prevent chronic disease in young people can dramatically improve health outcomes later in life. Childhood and adolescence are critical periods, when behaviours associated with NCD risk are adopted including tobacco use, alcohol use, substance abuse, unhealthy diets and sedentary lifestyles and children and young people are often targeted by commercial marketing of unhealthy products.

The aim of this topic is to fund implementation research, exploring strategies, evidence-based program and policy interventions across prevention, diagnosis, screening and management of chronic NCDs, centred on the critical life stages spanning early childhood to young adulthood (1-24 years of age) living in LMICs, and/or underserved populations in HICs.

In this regard, proposals focused on implementation research should explore implementation strategies on evidence-based interventions, adaptations of interventions and tailored interventions, or initiatives including (though not limited to) those focussed on one or more of the following:

• Policy evaluation to tackle childhood- and/or youth-relevant social, economic, political, structural or commercial determinants of chronic NCD conditions.

• Prevention of NCDs using children and/or young people targeted implementation strategies (e.g. educational strategies, vaccination strategies, promotion of behavioural and lifestyle changes).

• Screening and diagnosis of NCDs (or risk factors) in children and/or young people (in particular use of digital tools).

• Cost effective and patient-centred management of NCDs in children and/or young people (including access to medicines and equipment; integrated care pathways; continuity of care for adolescents with existing non-communicable diseases who "age out" of paediatrics, caregiver health and support, citizen science approaches).

Multiple interventions focus on prevention of NCDs in children and young people, yet relatively few have focussed on strategies for management of chronic conditions in these critical life stages, and a limited number of studies have been carried out to study implementation of these in LMIC contexts or with underserved communities. In this instance it would be anticipated that proposals should explore implementation strategies using the appropriate hybrid design study incorporating effectiveness and implementation research outcomes. Therefore, it may be important to undertake formative research as a part of the proposal to support readiness for implementation.

The proposed implementation research should be focused on one or more evidence-based interventions (or complex interventions), providing existing evidence of the intervention’s effectiveness, cost-effectiveness, sustainability, scalability and potential for long-term health and other impacts (and in what context this evidence has been generated).

Applicants should provide rationale and explore the implementation of proposed intervention(s) for a selected study population(s) based in one or more LMICs, and/or underserved populations experiencing health disparities, including Indigenous populations, in HICs, considering the unique social, political, economic, and cultural context(s) in which the study will take place[6]. Applicants should justify why any adaptation will not compromise the known effectiveness of the selected intervention(s).

Proposals should address all the following implementation research activities[7]:

• Clearly describe the implementation research methodology, including the statistical design.

• Have an appropriate strategy for measuring implementation research outcomes and real-world effectiveness outcomes and indicators.

• Specifically address issues of equitable implementation to ensure interventions reach the populations that need them the most.

• Engage an appropriately expert and skilled research team which can ensure a suitable multidisciplinary approach and that demonstrates equitable partnership and shared leadership between HIC-LMIC, and/or non-Indigenous-Indigenous members of the project team and external stakeholders through a clear governance strategy.

• Provide a stakeholder engagement strategy with evidence of support/engagement from key stakeholders for delivering the intervention and a pathway to sustain the proposed intervention (if proven effective) after the funding from the GACD grant ends.

• Provide opportunities for NCD-focused implementation research capacity building for early career researchers and team members from lower resourced environments, such as LMICs or disadvantaged communities.

• Ensure meaningful involvement of early career team members, including at least one early career member as a co-investigator.

The study population may include children and/or young people in the general population, with one or more existing NCDs, those currently without NCDs, or a combination of any of the above. Applicants may propose implementation research focused on interventions that are implemented at the individual, family, community (e.g. work or school), population, and/or structural level. With regard to NCDs, applicants are encouraged to explore any chronic non-communicable condition (or combination of conditions), including mental health disorders, autoimmune conditions, musculoskeletal conditions, neurological disorders and sleep disorders and/or any risk factor (or combination of risk factors). Additionally, whenever relevant, applicants are also encouraged to take a life course approach, adapting interventions for particular life stages with the goal of promoting life-long health.

Proposals should use an appropriate implementation research design and framework[8], before and after studies, and additional implementation science classifications of study designs (e.g. hybrid designs[9]), noting that applicants are not limited to any particular design.

Proposals would be expected to generate evidence that is of direct relevance to policymakers, communities and practitioners. Proposed work should identify and engage all key stakeholders necessary and relevant to the development, undertaking and knowledge translation phases of the project, including meaningful collaboration with young people themselves (and their families). Proposals should also consider using co-development and co-design approaches, involving policymakers, local authorities, community groups, educators, healthcare providers, and other individuals or organisations necessary to the delivery and sustainability of the study outcomes. Project partners should be engaged from the beginning to contribute to the sustainability of the intervention after the end of project. Proposals should demonstrate sustainability of the strategy, beyond the lifespan of the project.

Poverty, discrimination based on sex, racial or ethnic origin[10], religion or belief, disability, age, and other inequities are directly associated with reduced potential for equitable access to quality care. Proposals should consider relevant determinants of health (e.g. social, structural, commercial, economic) and discuss their potential impact on the effective implementation of the intervention(s). If there is a focus on a particular population (e.g. gender, racial or ethnic origin[10], etc.), then the reason for this should be justified.

This topic requires the effective contribution of social sciences and humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.

All projects funded under this topic are strongly encouraged to participate in networking and joint activities, including internationally, as appropriate. These activities could, for example, involve the participation in joint workshops, the Annual Scientific Meetings of the GACD, the exchange of knowledge, the development and adoption of best practices, or joint communication activities. Therefore, proposals are expected to include a budget for such activities and may consider covering the costs of any other potential joint activities without the prerequisite to detail concrete joint activities at this stage. The details of these joint activities will be defined during the grant agreement preparation phase.

Applicants should provide details of their clinical studies[12] in the dedicated annex using the template provided in the submission system. As proposals under this topic are expected to include clinical studies, the use of the template is strongly encouraged.

[1] As defined by the World Bank, https://www.worldbank.org

[2] https://www.gacd.org

[3] https://iris.who.int/bitstream/handle/10665/91758/9789241506212_eng.pdf

[4] https://www.taylorfrancis.com/chapters/oa-edit/10.4324/9781003306689-20/social-determinants-health-ncds-ruth-bell-jaime-miranda-jean-woo-michael-marmot

[5] https://data.unicef.org/topic/child-health/noncommunicable-diseases/

[6] Focus on populations facing extreme vulnerabilities, such as individuals or communities living in informal settlements, post-disaster settings, or in situations of homelessness is encouraged (though not required).

[7] The following types of proposals are not in the scope of this topic: i) proposals with the primary aim of informing the development and/or selection of an intervention for a given context, where the implementation component will be explored in a future project (i.e. standalone feasibility projects); ii) epidemiological cohorts; iii) etiological work, mechanistic, or epidemiological research, unless an essential component of a focused study to develop implementation research approaches; iv) clinical trials, validation studies, or intervention efficacy studies for a new or established pharmacological agent or behavioural intervention.

[8] Examples of frameworks include (this list is not exclusive): i) Consolidated Framework for Implementation Research (CFIR); ii) the context enhanced (RE-AIM) Reach, Effectiveness, Adoption, Implementation, Maintenance); iii) Practical Robust Implementation and Sustainability Model (PRISM) frameworks; iv) Framework for Developing and Evaluating Complex Interventions (MRC & NIHR).

[9] https://pmc.ncbi.nlm.nih.gov/articles/PMC3731143 and https://pmc.ncbi.nlm.nih.gov/articles/PMC6779135

[10] The use of the term ‘racial or ethnic origin’ does not imply an acceptance of theories that attempt to determine the existence of separate human races.

[11] The use of the term ‘racial or ethnic origin’ does not imply an acceptance of theories that attempt to determine the existence of separate human races.

[12] Please note that the definition of clinical studies (see introduction to this Work Programme part) is broad and it is recommended that you review it thoroughly before submitting your application.

Who can apply, in detail
Applicant types
SME, Large company, Research org, University, Public body
Purpose
Research and innovation
R&D relevance
2 of 3
Poland eligible
Yes
Country limit
—
Region
Any
Consortium
Unclear
Readiness level (TRL)
—
Topics
  • Child and adolescent health
  • Non-communicable diseases
  • Disease prevention
  • Health inequalities

Machine-classified from the call text; check eligibility at the source. 23 Oct 2026

Conditions38

Typed facts extracted from the source documents by Scindu's grant-data review. Each value keeps its own conditions. Unknown means unstated, not zero or unlimited.

Applicant restriction
Participation and funding eligibility are distinct. Eligible participation remains subject to the Horizon Europe Regulation and topic conditions. Beneficiaries and affiliated entities register in the Participant Register before submission to obtain a PIC; legal validation and proof of legal status/origin are completed before grant signature, but a validated PIC is not a submission prerequisite. Associated partners may participate subject to the topic without signing the GA or charging costs/claiming contributions. General funding categories include EU Member States (including outermost regions), Overseas Countries and Territories, Associated Countries, and the listed low-/middle-income countries. Other entities receive funding only where the topic provides or the granting authority finds participation essential. Check applicable country status/list and call-specific exceptions. The general consortium default, unless specific call/topic conditions provide otherwise, is three mutually independent beneficiary legal entities established in three different countries: at least one in a Member State and two others each in different Member States or Associated Countries. Affiliated entities do not count toward this minimum. The JRC, international European research organisations and entities created under EU law are treated as established in a Member State different from those of other participants. Training/mobility and CoFund applications may be submitted by one or more entities if one is established in a Member State or Associated Country. Apply the three-beneficiary default only subject to any express own-topic exception; none is inferred from action-class wording alone.
Applicant restriction
For this assigned topic the source-bound action class is RIA. Apply the general China rule by that class: the IA bar applies to IA; the default RIA bar and its listed exceptions apply only to RIA and only for the matching Work Programme destination. Do not transpose either rule to CSA, PCP or CoFund. The all-action MIIT-supervised Chinese public-university exclusion remains applicable. General Annex B: China-established legal entities are excluded from every IA and, unless stated otherwise, every RIA. The listed RIA destination exceptions are Cluster 2: Innovative Research on Democracy and Governance; Innovative research on European cultural heritage and cultural and creative industries; Innovative research on social and economic transformations. Cluster 5: Climate sciences and responses for the transformation towards climate neutrality. Cluster 6: Biodiversity and ecosystem services; Fair, healthy and environment-friendly food systems; Clean environment and zero pollution; Land, ocean and water for climate action; Resilient, inclusive, healthy and green rural/coastal/urban areas; and Innovative governance, environmental observations and digital solutions in support of the Green Deal. Missions: EU Missions’ Joint Calls; Adaptation to Climate Change; Restore our Ocean and Waters; and A Soil Deal for Europe. Widening: Widening participation and spreading excellence; Reforming and enhancing the European research and innovation system. New European Bauhaus Facility: Connecting the green transformation, social inclusion and local democracy; Innovative funding and new business models for neighbourhood transformation. Horizontal Activities: Transformative change towards a nature-positive economy and society. The listed destination exceptions are RIA exceptions only: they do not lift the China-established-entity exclusion for an IA. For an RIA, a China-established entity is excluded unless this call’s exact destination is one of the listed RIA exceptions; only when the destination matches may the entity participate in any capacity. A justified case-by-case exception may also be granted under the source rule. For IA and RIA restrictions that apply, exclusion covers participation in any capacity. MIIT-supervised Chinese public universities remain ineligible for any action. Evaluate this packet’s own action and exact destination before applying an exception. Entities subject to EU restrictive measures are not eligible in any capacity, including beneficiaries, affiliated entities, associated partners, third parties giving in-kind contributions, subcontractors or recipients of FSTP. Entities established in Russia, Belarus or non-government-controlled territories of Ukraine are likewise ineligible in any capacity even when not subject to EU restrictive measures; a justified case-by-case exception may be granted. Russian-established persons/entities/bodies whose direct or indirect proprietary rights exceed 50% in an entity established outside Russia make that entity ineligible in any capacity. These rules are distinct from call-specific ownership/control restrictions, which apply only when identified in the relevant Work Programme/topic conditions. Communications-network supplier restrictions and critical-technology/control restrictions apply only when identified in the relevant work-programme/topic conditions; they are not automatic for every call. Russian-established persons/entities/bodies that directly or indirectly hold proprietary rights exceeding 50% in an entity established outside Russia make that entity ineligible in any capacity. Hungarian public-interest trusts established under Act IX of 2021 and entities they maintain may apply, but while Council measures remain in force cannot take any funded role (including beneficiaries, affiliated entities, subcontractors, or recipients of FSTP); in multi-beneficiary calls the applicant is invited to remove/replace them from funded roles or change them to associated-partner status, with tasks and budget redistributed accordingly. Affected entities can participate without EU funding as associated partners if call conditions allow. These conditions do not establish eligibility for any particular participant.
Applicant restriction
Financial capacity is normally checked for the coordinator when requested grant is at least EUR 500,000, with exceptions for public bodies/international organisations and individual requested amounts no more than EUR 60,000. Checks may extend to other applicants, affiliated entities or guarantors; weak capacity can lead to safeguards or rejection. Operational capacity is assessed through the implementation award criterion; the form requests participant/researcher identity, up to five relevant achievements and up to five relevant prior projects/activities per participant, plus significant infrastructure/equipment. Public bodies, Member State organisations and international organisations are exempt from that operational-capacity check. Administrative sanctions and listed exclusion grounds bar participation, including insolvency, tax/social-security breaches, grave professional misconduct, fraud/corruption/criminal and financial-integrity offences, serious prior grant/contract failures, irregularities, circumvention and unremediable procurement-preparation conflicts; misrepresentation/non-supply and irremediable equality-of-treatment distortion are also refusal grounds. These legal/capacity checks are separate from award scores and do not certify a specific participant.
Applicant restrictionAdopted General Annex B; only if the own-topic action activates this restriction
Where the specific action is expressly identified as subject to restrictions for protection of European communication networks, entities assessed as high-risk suppliers of mobile network communication equipment and entities they own or control are ineligible as beneficiaries, affiliated entities or associated partners. Assessment includes third-country interference/ownership/governance/business/legal context, supply-chain cybersecurity practices and relevant security assessments. Exceptions may be requested from the granting authority, which assesses them case by case using the 5G toolbox criteria, security risks and availability of alternatives in the action. This conditional general clause does not activate the restriction for an unflagged topic or extend the listed participation roles.

Own-topic activation and other separately stated country/control restrictions retain their distinct scope.

Applicant restriction
General Annex B restrictions apply, including the default exclusion of entities established in China from Health RIAs, participation of MIIT-supervised Chinese universities, EU restrictive measures, and the applicable Hungarian public-interest-trust restriction. Exceptions/changes require individual checking; the US funding exception does not waive other restrictions.
Applicant type
Legal entities subject to Horizon Europe Regulation, General Annex B and topic-specific conditions; participation does not itself establish eligibility for funding.
Application restriction
Submit electronically using the forms in the Portal system (topic-page templates are informational), following the form instructions. Applications must include all parts and mandatory annexes/supporting documents and be readable, accessible and printable. Full applications include an exploitation/dissemination/communication plan unless the topic provides otherwise; no such plan is required for stage 1 of a two-stage process. Where relevant, include a commercial exploitation strategy; where exploitation is primarily in non-associated third countries, explain why it is in the EU interest. General Annex A defaults: full application 40 pages, except CSA 25 and Programme Co-fund 65; for lump-sum topics RIA/IA 45 and CSA 28; stage 1 is 10 pages. The specific topic and actual Portal form/template override defaults. Blind first-stage anonymisation applies only when the topic specifies blind evaluation. If an application exceeds the applicable page limits, the submission system gives an automatic warning and invitation to resubmit a conforming version. After the call deadline, excess pages are automatically made invisible and are not considered by evaluators. Actual topic conditions and Portal submission templates govern the applicable limits and sections. This procedure does not promise a post-deadline correction window or say the whole application is automatically rejected.
Application restriction
Projects must focus exclusively on civil applications and comply with EU policy interests/priorities. Applicants complete an ethics self-assessment; projects raising ethics issues undergo ethics review and may receive ethics deliverables/authorisation requirements. Security appraisal/classified-information conditions apply only when classified or sensitive information is involved. A GEP is an eligibility requirement at grant signature and throughout the grant only for MS/AC public bodies, research organisations and higher-education establishments applying as beneficiaries or affiliated entities. It must be published, top-management-signed/adopted, resourced, monitor sex/gender-disaggregated data with reporting at least every two years, and include staff/decision-maker awareness or training; equivalent strategic documents can satisfy the process requirements. GEP eligibility does not apply to other legal-entity categories. Separately, beneficiaries must take measures to promote equal opportunities and, where applicable, follow the GEP; they should aim, to the extent possible, for gender balance at all personnel levels, including supervisory/managerial levels. This is an implementation aim, not a numerical staffing quota. A self-declaration is requested in the Participant Register. Source-listed GEP content areas are recommendations, not extra mandatory eligibility items.
Application restriction
Full applications: Excellence, Impact and Implementation each have threshold4/5, cumulative threshold12. Passing thresholds enters budget-limited ranking, not an award. Any own first-stage rules are additional and scoped separately.
Application restrictionHORIZON-HLTH-2027-01-DISEASE-10; adopted AnnexE, subject to stage-specific templates
Use the electronic Portal system and complete all parts, mandatory annexes and supporting documents. PartA contains organisation/administrative data, summary budget and call questions; PartB is the technical PDF description. Upload supporting documents in system-permitted formats. Design the proposal around the award criteria. Coordinator confirms mandate, correctness/completeness and all participants’ eligibility/capacity/exclusion compliance; each participant reconfirms by declaration of honour before signature. Noncompliance can cause rejection and later legal-entity/financial/bank validation documents may be requested. Actual stage-specific Portal templates and own-topic conditions govern.
Application restrictionEvaluation review; actual/deemed access anchors, not submission or project deadlines
Coordinator may request review of procedural flaws, following evaluation-result-letter procedures/deadlines; merits are not reviewed. Each request concerns one specific proposal, within30days after opening/access of results, maximum7000characters. Notifications unopened for10days after sending are deemed accessed. A review committee may recommend re-evaluation, primarily by experts not involved previously, or confirmation of the initial evaluation.
Application restrictionDefault full-application ranking within one budget envelope; own special arrangements retained
Adopted General Annex F default for proposals with the same score within one budget envelope, excluding stage 1 of two-stage submissions and subject to any specific call/topic special arrangement: first prioritise call aspects not covered by more highly ranked proposals. Those identified proposals are then prioritised by Excellence and then Impact; for Innovation Actions the order is Impact then Excellence. If necessary, use gender balance among named leading researchers; then geographical diversity by MS/AC not otherwise receiving funds from higher-ranked projects (number first, then budget if equal). If still indistinguishable, the panel may use documented call/Horizon-objective factors, for example project-portfolio synergies or relevant feasible SME involvement. This is a priority procedure, not a funding guarantee, staffing quota or first-stage tie rule.
Application restriction
Proposals should address all listed implementation activities: describe methodology including statistical design; measure implementation-research and real-world-effectiveness outcomes/indicators; address equitable implementation; build a suitably expert multidisciplinary team demonstrating equitable partnership/shared leadership between HIC-LMIC and/or non-Indigenous-Indigenous team members and external stakeholders through clear governance; provide stakeholder engagement/support evidence and a post-grant sustainability pathway; create NCD implementation-research capacity building for early-career researchers/team members from lower-resourced environments; and meaningfully involve early-career team members, including at least one early-career co-investigator as the topic says proposals should do. Use an appropriate implementation design/framework; hybrid designs and formative research may be considered/anticipated but the call does not require one named design.
Application restriction
Planned opening 29 October 2026; single-stage deadline 17 February 2027, 17:00 Brussels local time. The WP permits the responsible Director-General to shift opening by up to one month and delay deadlines by up to two months. No live submission acceptance is asserted.
Consortium required
Yes
Eligible geography
General Annex B permits funding for entities in EU Member States, linked OCTs, associated countries, the listed low/middle-income countries, and other countries where the topic provides or the granting authority considers participation essential. These topics additionally allow US legal entities to receive Union funding. Country status and restrictive measures require applicant-specific checking.
Eligible project scope
Proposals should explore implementation strategies for evidence-based, adapted or tailored interventions. Existing evidence of effectiveness, cost-effectiveness, sustainability, scalability and potential long-term health/other impacts should be presented with the context where generated; justify adaptations that might compromise known effectiveness. Provide rationale for the selected LMIC and/or underserved HIC population, considering the unique social, political, economic and cultural context. Focus on extreme vulnerability (informal settlements, post-disaster settings, homelessness) is encouraged, not required. Study populations and implementation levels may vary as described in the call; broad NCD/risk-factor choices are permitted.
Eligible project scope
GACD-aligned implementation research on evidence-based programme/policy interventions for prevention, diagnosis, screening and management of chronic NCDs among children/young people aged 1–24 in LMICs and/or underserved populations (including Indigenous populations) in HICs. Applicants should use interventions with existing evidence of effectiveness, cost-effectiveness, sustainability, scalability and long-term impact, explain the context generating that evidence, and justify any adaptation so it does not compromise known effectiveness. Study populations may be general-population youth, those with existing NCD, currently without NCD, or combinations; implementation may occur at individual, family, community/work/school, population and/or structural level. Any chronic NCD/combination or risk factor may be addressed, including mental, autoimmune, musculoskeletal, neurological and sleep disorders; life-course tailoring is encouraged. Proposals should use an appropriate implementation-research design/framework and should address all following activities: methodology/statistical design; measures for implementation and real-world effectiveness outcomes; equitable reach; expert multidisciplinary team with equitable HIC-LMIC and/or Indigenous/non-Indigenous partnership/shared leadership and clear governance; evidenced stakeholder support/engagement and sustainment pathway; capacity-building for early-career researchers/team members in lower-resourced environments; and meaningful early-career involvement including at least one early-career co-investigator. Standalone future-feasibility, epidemiological cohorts, etiological/mechanistic/epidemiological work unless essential to focused implementation approaches, and efficacy/validation trials of agents or behavioural interventions are excluded.
Expected number of grants (planning estimate)Captured SEDIA planning estimate for exact topic HORIZON-HLTH-2027-01-DISEASE-10
3 count

Expected funded-project/grant count in the exact provider topic budgetOverview. Indicative planning metadata, not guaranteed awards, maximum accepted projects, staffing or consortium size. It does not replace any differently expressed work-programme planning range.

Ineligible project scope
Exclude standalone feasibility projects for later implementation research, epidemiological cohorts, mechanistic/etiological/epidemiological work unless essential to focused implementation research, and efficacy/validation trials of new or established agents or behavioural interventions.
Other condition
Research and Innovation Action (RIA).
Other condition
For this explicitly lump-sum topic, evaluators provide comments on the detailed lump-sum budget table in the Evaluation Summary Report only for proposals invited to grant-agreement preparation, proposals placed on the reserve list, and proposals rejected (in part) because costs were significantly overestimated or underestimated. This limits ESR budget-table comments; it does not change the funding model or imply that comments are otherwise a condition of award.
Other condition
Where the project uses satellite earth-observation, positioning, navigation or related timing data/services, beneficiaries must use Copernicus and/or Galileo/EGNOS; other data and services may be additional.
Other condition
Project starting date and duration are fixed in the grant agreement. No numerical duration is asserted from the indicative funding table.
Other conditionHORIZON-HLTH-2027-01-DISEASE-10; RIA full-application award aspects; not first-stage full-rubric scoring
For RIA full applications evaluated under adopted AnnexD, assess the action-specific qualitative aspects. Excellence: clarity/pertinence of objectives and ambition beyond the state of the art; sound methodology, including underlying concepts/models/assumptions, interdisciplinary approaches, appropriate research-content gender dimension, and quality of open-science practices including research-output sharing/management and citizen/civil-society/end-user engagement where appropriate. Impact: credible pathways to expected work-programme outcomes/impacts; suitable, high-quality measures to maximise them through the dissemination/exploitation plan, including communication. Implementation: effective, high-quality work plan, risk assessment, appropriate work-package effort and overall resources; each participant’s capacity/role and the consortium’s necessary expertise. Aspects are considered to the extent relevant to the work-programme description; scores are for criteria, not separate scores for each aspect. Own-topic exceptions and the separately recorded stage-specific score rules retain priority.
Other conditionGeneral Annex F default limitations; individual part budget denominator and call-specific procedures
Invitation to grant preparation is no formal funding commitment; legal/capacity/exclusion checks remain. Call/topic budgets are indicative; unless otherwise stated final figures may change up to20% relative to the total budget in each individual work-programme part, not an automatic project or topic increase. Seals of Excellence/STEP seals, joint-call selection, blind first-stage evaluation and partial randomisation depend on explicit own-call conditions; none follows automatically from two-stage status. The tie method in points1–4 is reapplied to remaining equally ranked proposals.
Other conditionDefault indicative evaluation/grant-preparation timetable; own-topic timeline prevails
Absent different own-call conditions, evaluation outcome is around5months after submission deadline and grant signature around8months. Two-stage default: around3months from stage1deadline for its outcome; around5months from stage2deadline for its outcome, and around8months from stage2deadline for grant signature. Indicative planning estimates, not fixed promises or project/employment duration.
Other conditionHORIZON-HLTH-2027-01-DISEASE-10; adopted General Annex G baseline subject to express own-topic grant provisions and actual agreement
Grant preparation with the EU project officer sets deliverables, reporting/payments, grant amount, rate, eligible costs and duration in the agreement. Budget is EUR and award may be below request. Start normally follows signature; retroactive start and month-based duration extensions need exceptional justified granting-authority agreement. Portal manages milestones/deliverables reflected in agreementAnnex1. For ACTUAL-COST grants only eligible incurred costs are reimbursed at the agreed rate; surplus/profit is deducted and noncompliance may reduce grant. This conditional actual-cost description does not reclassify an expressly lump-sum/unit topic: its rate is already applied in amount-setting and does not appear as a separately added reimbursement percentage. Own-topic grant form/rate, PCPprocurement conditions and partnership amendment restrictions remain.
Other conditionHORIZON-HLTH-2027-01-DISEASE-10; adopted General Annex G baseline subject to express own-topic grant provisions and actual agreement
Agreement covers proper implementation, conflicts, confidentiality/security/classified information, ethics/integrity/values/gender, data protection, IPR/background/results/access/use, communication/dissemination/open science/visibility and applicable special action rules. Additional adopted duties: if granting authority requests during a public emergency, grant nonexclusive result licences on fair/reasonable terms for its stated limited period to entities committed to rapid broad exploitation; provision applies up to4years after action end. Unless own-call states otherwise, notify authority for up to4years after end when results could reasonably contribute to European/international standards. Authority may object to ownership transfer/exclusive licensing for up to4years after end ONLY where specific call provides. Give data/result access needed to validate publication conclusions while safeguarding legitimate interests/constraints unless access already given. On authority request in public emergency, immediately deposit research outputs and provide CC BY,CC0 or equivalent open access; where legitimate interests preclude this, provide the stated nonexclusive fair/reasonable licences instead, with that exception limited to4years after end. Breach/other legal violations may trigger agreementChapter5 measures; no unread AGA provisions or executed applicant agreement are asserted.
Other conditionHORIZON-HLTH-2027-01-DISEASE-10; adopted General Annex G baseline subject to express own-topic grant provisions and actual agreement
After signature, normal initial float is160% of average EU funding per reporting period: maximum grant amount divided by number of reporting periods. Exceptionally less or no pre-financing is possible. With ONLY ONE reporting period it will be less, since100% would already equal the whole grant; no fixed single-period percentage is specified. Programme co-fund actions may receive additional pre-financing. At pre-financing,5–8% of maximum grant is deducted into the mutual-insurance mechanism, not added as a benefit or treated as funding intensity. EU debts may offset/reduce payments. Interim payments link to periodic reports; final report determines final grant and overpayment is recovered. Financial-statement certificate thresholds depend on grant size/beneficiary type and the agreement, not an invented universal amount. Recovery liability is individual: beneficiary’s own and affiliated-entity debts. These normal/general arrangements do not guarantee a new payment on an existing partnership amendment or displace express own-topic/agreement provisions.
Other condition
The own-topic call-overview row plans an indicative 3 projects expected to be funded. This is a programme planning count, not consortium size, job headcount, guaranteed awards or remaining allocation. Proposed dedicated numeric semantic type is supplied separately.
Other condition
Eligible costs take the form of a lump sum under the cited Horizon Europe lump-sum decision. Underlying budget estimates follow actual-cost eligibility rules but do not establish payroll reimbursement or a personal stipend.
Other condition
Lump-sum interim payments concern accepted completed work-package shares; partial work-package payment is possible at project end under the guide conditions. Actual payroll expenditure does not determine the share.
Other condition
Proposals should aim to contribute to some of four outcomes: improved insights/evidence for equitable early prevention, risk reduction and timely diagnosis for children/youth in LMICs or disadvantaged HIC populations; evidence/recommendations for national programmes/policies to improve youth quality of life and healthy life expectancy; better understanding of adaptation/scaling-up of NCD interventions locally, regionally and nationally; and full engagement of communities, families, young people, local stakeholders and authorities in implementation and uptake.
Other condition
Work should identify and engage relevant stakeholders through development, implementation and knowledge translation, including meaningful youth/family collaboration; co-development/co-design should be considered. Partners should engage from the beginning and demonstrate sustainability beyond the project. Consider relevant social/structural/commercial/economic determinants and justify any focus on a particular population. Effective SSH contribution is required. Funded projects are strongly encouraged to participate in appropriate joint/networking activities including international work and GACD Annual Scientific Meetings; proposals are expected to include a budget for these activities, while concrete activities need not yet be specified. Applicants should provide clinical-study details in the dedicated template annex; studies are expected and template use is strongly encouraged. The expected clinical-study template information does not place within scope the standalone clinical trials, validation studies or intervention-efficacy studies expressly excluded above; clinical-study detail expectations remain subject to that scope boundary.
Other condition
The granting authority may object to ownership transfer or exclusive licensing of results up to four years after action end, under the specific Annex 5 provision.
Partner requirement
At least three independent beneficiary legal entities in three different countries: at least one in an EU Member State and at least two others in different EU Member States or Associated Countries. Affiliated entities do not count toward this minimum.
Staff restriction
The team should demonstrate a suitable multidisciplinary approach, equitable partnerships/shared leadership, implementation-research capacity building and meaningful early-career involvement. Social sciences/humanities expertise and experts/institutions are required; this does not prescribe new employment.
Amounts and costs9
Indicative budget
€11,800,000

Topic budget as stated in the portal's budget table. Lump-sum and per-project limits are in the call conditions.

Eligible costHORIZON-HLTH-2027-01-DISEASE-10; express lump-sum grant budget; applicable decision/template qualifications retained
For this expressly lump-sum topic, provide the detailed estimated budget table to justify/fix the lump sum, approximating costs actually incurred and satisfying basic EU actual-cost eligibility conditions. Purchases and subcontracting must ensure best value for money (or lowest price where appropriate) and be free of conflicts of interest. Ineligible table costs can reduce the grant even during implementation or after completion. Only an exceptional action-specific authorising decision may waive the detailed table. This is amount-setting/cost-eligibility methodology, not reimbursement of every actual expense or a salary entitlement.
Eligible costHORIZON-HLTH-2027-01-DISEASE-10; adopted General Annex G baseline subject to express own-topic grant provisions and actual agreement
Agreement fixes cost forms/categories: eligible actual personnel/subcontracting/purchases and FSTP only if call permits; units may cover personnel, SMEowners/naturalpersons without salary, usual-practice average personnel and internally invoiced goods/services, and expressly permitted specific units. The25%indirect-cost base excludes subcontracting,FSTP and units/lump sums already containing indirect costs. Different cost forms can coexist; global/action-category lump sums require call provision. Several EU Synergy grants may declare costs only where cumulative funding does not exceed100% of eligible costs/contributions declared. These are budget/eligibility methods, not personal salary or automatic FSTP/unit-cost permission; separately recorded own-topic costs/forms and rates retain priority.
Eligible cost
Budget for networking/joint activities such as GACD annual scientific meetings; concrete activities may be defined during grant preparation.
Eligible cost
General Annex G includes personnel costs, subcontracting and purchases among eligible budget categories subject to the grant agreement. Personnel may use applicable actual-cost or unit-cost forms. This is a cost category, not an advertised vacancy, mandatory hire, salary scale, headcount or FTE entitlement.

For the explicit lump-sum topic, eligible personnel estimates help establish the lump sum; salary reimbursement is not asserted.

Funding intensity, maximum
100 percent of eligible costs

General Annex G maximum RIA funding rate, applied to eligible costs under the applicable grant model; not a percentage of project turnover or of an unrestricted total budget. For the GACD lump-sum topic it is part of fixing the lump-sum amount, not a payroll reimbursement promise.

Indirect cost flat rateGeneralAnnexG indirect costs for this Horizon action/grant methodology
25 percent of the named eligible-direct-cost base

Base: total eligible direct costs excluding subcontracting, financial support to third parties and any unit costs/lump sums already including indirect costs. Apply only within the relevant grant/budget methodology; for lump sums this contributes to amount-setting, not an extra actual-cost payment or wage rate.

Expected project funding, up to
€4,000,000

Indicative expected EU contribution, not a hard cap; the topic explicitly allows selection of different requested amounts.

Expected project funding, from
€3,000,000

Indicative expected EU contribution; proposals requesting different amounts may be submitted and selected. This is not a minimum eligible project budget or guaranteed award.

Topic allocation
€11,800,000

Total indicative topic allocation; not an applicant/project entitlement or current unspent balance.

Personnel and services1
  • Researcher

    Basis not stated

    The stated headcount is a source-described project-team recommendation framed as SHOULD, not a hard applicant-eligibility or funding exclusion condition. No salary, contract, FTE or duration is specified.

Source documents3
Call facts
Opens
29 Oct 2026
Deadline model
Single-stage
Programme
Horizon Europe · 2021 - 2027
Call
HORIZON-HLTH-2027-01 · Cluster 1 - Health (Single stage - 2027/1)
Types of action
HORIZON Research and Innovation Actions
Keywords
  • GACD
  • Global Alliance for Chronic Diseases
  • NCD
  • adolescence
  • childhood
  • chronic diseases
  • evidence-based interventions
  • implementation research
  • non-communicable diseases
  • young adulthood
Checked
24 Oct 2026
Portal updated
7 Oct 2026
Review status
Partial review
Reviewed
24 Oct 2026

This is a summary of the source page, not the official text. Eligibility, conditions and the submission system are at the source.